FINAL REPORT GENERAL PUBLIC BACKGROUND INFORMATION AND RECOMMENDATIONS
|
|
- Earl Barber
- 6 years ago
- Views:
Transcription
1 Using Multidimensional Prognostic Indices to improve cost-effectiveness of interventions in multimorbid, frail older persons FINAL REPORT GENERAL PUBLIC BACKGROUND INFORMATION AND RECOMMENDATIONS
2 INTRODUCTION The MPI_AGE project is a research project co-funded by the European Union through the Health Programme that has explored ways to reduce unnecessary use of health care resources in older subjects by improving the quality of the medical interventions needed and adapting them to the individual needs of the subject. Most of the work in this project is based on the use of a well-validated diagnostic and prognostic tool, named Multidimensional Prognostic Index (MPI). This tool gathers information obtained from a multidisciplinary assessment of each patient, called Comprehensive Geriatric Assessment (CGA). CGA has been shown to be very useful in improving the adaptation of health interventions to older people that suffer from many diseases and are especially complex. WHAT ARE THE OBJECTIVES OF THIS RESEARCH? The aims of the MPI_AGE project were to: identify the most cost-effective health interventions according to the expected survival of a given person; improve interactions and cooperation among health care professionals to prepare care plans that are adapted to the risk and needs of each person, defined by the MPI; develop adapted intervention programs based on the individual MPI-profile of each older person; explore ways to reduce health-related costs by reducing those that may be inappropriate, especially hospital admissions, time in hospital, need of nursing home and unnecessary prescription drug use.
3 PARTNERS OF MPI_AGE The MPI_AGE project involves the following centers and organizations in twelve different countries. ASSOCIATE PARTNERS Italy: AULSS16 - Azienda Unità Locale Socio Sanitaria nº 6 Euganea, Padova (Coordinating center) Czech Republic: Univerzita Karlova, Prague France: CHU, Poitiers Germany: Universitätsklinikum Köln, Cologne Netherlands: Erasmus Universitair Medisch Centrum, Rotterdam Spain: Fundación Para la Investigación Biomédica del Hospital Universitario Ramon y Cajal, Madrid Sweden: Karolinska Institute, Stockholm Europe: European Union Geriatric Medicine Society (EUGMS) COLLABORATING PARTNERS Australia: Flinders University, Adelaide Belgium: EUREGHA; AGE platform Europe Bulgaria: Bulgaria Association on Ageing Estonia: Estonian Association of Gerontology Italy: Regione del Veneto - Servizio per le relazioni socio-sanitarie; Centro Regionale Management Progetti Europei CReMPE; National Research Council CNR; IRCCS Casa Sollievo della Sofferenza; Università degli Studi di Messina; E.O. Ospedali Galliera di Genova Hungary: Semmelweiss University, Budapest United States of America: National Institute on Aging; John Hopkins Bloomberg School of Public Health
4 WHAT IS THE MULTIDIMENSIONAL PROGNOSTIC INDEX (MPI)? MPI is a diagnostic and prognostic tool based the comprehensive assessment of older persons. We already know that MPI is good to predict survival and other problems (hospitalization, admission to nursing homes). The original MPI includes information in 8 areas: 1. Activities of Daily Living (self-care) 2. Instrumental Activities of Daily Living (cooking, cleaning, caring of drugs and finances, etc.) 3. Mental status 4. Nutrition status 5. Risk of suffering bed sores 6. Number of diseases and their global burden 7. Number of drugs used 8. Living arrangements A computer program ( calculates the MPI score, which ranges from 0 (good health, low risk of dying) to 1 (bad health, high risk of dying). HOW WAS THE MPI CREATED? The MPI was developed in Italy, by using data from many patients to find what functional and health aspects were more powerful in measuring prognosis in complex patients. In these studies, the aggregated data included in MPI showed to be able to predict death on the short and long term in geriatric patients. It has also shown to be useful in persons suffering particular diseases, as gastrointestinal bleeding, pneumonia, heart failure, dementia, liver cirrhosis, chronic kidney disease and transient ischemic attacks. The MPI has been studied in hospitals, in people living at home, and in care homes. It seems to be more accurate and reliable that other similar instruments. WHAT DID WE LEARN DURING THE MPI_AGE STUDIES? The MPI_AGE project, by including many partners, has been able to advance in the use of MPI in many different settings and groups of patients. These are some of the results of the studies performed: 1. Usually, MPI is performed in older people by a face-to-face assessment. However, it was not known if data from large medical databases could be used to calculate the MPI score. We were able to use databases from Sweden to extract the MPI, and showed that this version of the MPI was able to predict long-term survival (up to 12 years) and also the risk of hospitalization. 2. We also used an Italian database of people with dementia living in their homes, who applied to receive social services. In this population, MPI was again good in predicting mortality. We were also able to show that those individuals who were receiving anti-dementia drugs had a reduced mortality only if they were not in very poor health: those who had a high (bad) MPI did not benefit from drugs any more. This may be useful to know when drugs have to be stopped and a more palliative approach used in people suffering from severe dementia.
5 3. In another study, we analyzed a database from UK, with information gathered by general practitioners. Unfortunately, in this database we were unable to extract a complete MPI score, although we showed that some information that is part of the MPI (functional and cognitive measures) also predicted 1-year mortality. 4. Frail older subjects are usually excluded from clinical trials of new drugs, which puts them at risk by using drugs that were never researched in them. We used the MPI to find out what was happening in real life with two drugs frequently used in older people but not without risk: statins (drugs to reduce cholesterol) and anticoagulants (used to reduce the risk of stroke in patients with a common cardiac arrhythmia atrial fibrillation). a. In a large database from Italy, we looked at subjects with diabetes (who have higher cardiovascular risk than non-diabetics) and showed that using statins to lower cholesterol was effective in reducing mortality in all groups, from the healthiest to the more complex or disabled patients. This was confirmed in a second group who had already heart problems (coronary artery disease). We also found that the frailest were less likely to be treated with statins. b. We looked at older people with atrial fibrillation who were using anticoagulants and found that anticoagulants were useful to reduce mortality regardless of poor health and functional conditions. This reinforces the safety of the use of anticoagulants in older complex patients. 5. Sometimes older patients are excluded from innovative techniques or interventions due to old age, not considering the actual health and functional status of a given individual. Decisions based only on age are usually discriminatory, they are called ageism. We studied the use of MPI to help deciding who benefits of a given intervention by prospectively measuring MPI in patients aged 75 years who had a severe age-related heart valve problem (aortic stenosis) and were treated with a modern yet expensive - technique that skips the need of surgery (transcatheter aortic valve implantation, TAVI). We showed that MPI is good in predicting mortality depending on baseline status, so MPI may help patients and doctors decide whether this technique is appropriate for them. 6. Finally, the main contribution of MPI_AGE was a major international study exploring if MPI was useful in predicting what happens during hospital admission and one year after admission in very frail complex patients (named geriatric patients) hospitalized in geriatric wards. In this large effort (the MPI_AGE multicenter trial) we were able to enroll 1,148 patients in 9 international centers across Europe and Australia. They were very old (mean age was 84 years), complex and acutely ill. They were classified according to their MPI score at hospital admission and discharge, and followed for one year. We obtained very important results from this study, in summary: a. We showed that the MPI score obtained at hospital admission was a very reliable predictor of mortality. We classified patients in three levels: those in the second level had 3 times the risk of dying in hospital, those in the third level had more than 10 times the risk of dying. MPI also predicted how long patients stayed in the hospital. This information may be useful for patients and their health care providers to make decisions on the care needs. If fact, MPI was associated with different profiles of use of diagnostic tests during admission. b. We also showed that the MPI score obtained at hospital discharge predicted well the risk of mortality in the year after discharge. MPI also predicted patients that had a higher risk to be readmitted to the hospital along that year, and those in need of home services or admission to nursing homes. c. MPI changed from admission to discharge in most patients, roughly improving in one out of three and worsening in one out of four. Those who improved had reduced mortality after discharge, those who deteriorated had an increased need of home services after discharge.
6 MPI_AGE RECOMMENDATIONS AND CONCLUSIONS Health interventions should be adapted to the individual needs of older people, especially for those who are very sick, have multiple health problems or are physically or mentally impaired. Healthcare professionals should assess the needs of each individual in an objective, reproducible way. Assessment has to consider every aspect of health and function that are relevant to each person. Objective assessment of needs may avoid discrimination of older people (ageism) in health care. The Multidimensional Prognostic Index (MPI) has proved to be an excellent objective assessment instrument in various healthcare settings (community, hospital, nursing homes) and across a wide range of diseases and conditions. MPI also identifies problems in several domains that may benefit from specialist comprehensive geriatric care. Tailored healthcare interventions have the potential to reduce the inappropriate and potentially harmful use of resources (hospitalizations, drugs, invasive procedures) and to allow well-established treatments and interventions to be used in older people who can benefit from them. Tailored healthcare interventions have the potential to reduce inappropriate health-related costs. MPI can be used to find out whether different treatments or interventions work in different older people. In older people who are hospitalized MPI identifies those at higher or lower risk of mortality or hospitalization for excessively long periods. MPI can also predict who will have a more/less favourable outcome and who will need social support (home-care services) or nursing-home care after hospitalisation.
7 REFERENCES Angleman SB, Santoni G, Pilotto A, Fratiglioni L, Welmer AK on behalf of the MPI_AGE Project Investigators. Multidimensional Prognostic Index in association with future mortality and number of hospital days in a population-based sample of older adults: results of the EU funded MPI_AGE Project. PLoS One 2015;10:e Brunello A, Fontana A, Zafferri V et al. Development of an oncological-multidimensional prognostic index (Onco-MPI) for mortality prediction in older cancer patients. J Cancer Res Clin Oncol May;142(5): Bureau ML, Liuu E, Christiaens L et al. on behalf of the MPI_AGE Project Investigators. Using a multidimensional prognostic index (MPI) based on comprehensive geriatric assessment (CGA) to predict mortality in elderly undergoing transcatheter aortic valve implantation. Int J Cardiol Jun 1; 236: D Onofrio G, Sancarlo D, Addante F et al. A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer s disease. Int J Geriatr Psych 2015;30: Daragjati J, Musacchio C, Polidori MC et al. on behalf of the MPI_AGE Investigators. Multidimensional Prognostic Index in hospitalized elderly patients across Europe and Australia: a prospective multicenter study of the European MPI_AGE project. Eur Geriatr Med 2016; 7(S1):S16. Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: a review. Eur J Int Med 2016;31:3-10. Fontana L, Addante F, Copetti M et al. Identification of a metabolic signature for multidimensional impairment and mortality risk in hospitalized older patients. Aging Cell (3): Gallucci M, Battistella G, Bergamelli C, et al. Multidimensional Prognostic Index in a cognitive impairment outpatient setting: mortality and hospitalizations. The Treviso Dementia (TREDEM) Study. J Alzheimer s Dis 2014;42: Giantin V, Valentini E, Iasevoli M et al. Does the Multidimensional Prognostic Index (MPI), based on a Comprehensive Geriatric Assessment (CGA), predict mortality in cancer patients? Results of a prospective observational trial. J Geriatr Oncol 2013; 4: Giantin V, Falci C, De Luca E et al. Performance of the Multidimensional Geriatric Assessment and Multidimensional Prognostic Index (MPI) in predicting negative outcome in older adults with cancer. Eur J Cancer Care 2016 Oct 10; doi: /ecc [Epub ahead of print]. Gill TM. The central role of prognosis in clinical decision making. JAMA 2012; 307: Mangoni AA, Pilotto A. New drugs and patient-centred end-points in old age: setting the wheels in motion. Expert Rev Clin Pharmacol 2016; 9 (1): Pilotto A, Ferrucci L, Franceschi M, et al. Development and validation of a multidimensional prognostic index for 1-year mortality from the comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res 2008;11: Pilotto A, Addante F, D Onofrio G, Sancarlo D, Ferrucci L. The Comprehensive Geriatric Assessment and the multidimensional approach. A new look at the older patient with gastroenterological disorders. Best Pract Res Clin Gastroenterol 2009;23: Pilotto A, Addante F, Ferrucci L et al. The Multidimensional Prognostic Index (MPI) predicts short and long-term mortality in older patients with community-acquired pneumonia. J Gerontol A Biol Med Sci 2009;64: Pilotto A, Sancarlo D, Panza F, et al. The Multidimensional Prognostic Index (MPI) based on a Comprehensive Geriatric Assessment predicts short- and long-term mortality in hospitalized older patients with dementia. J Alzheimer s Dis 2009;18: Pilotto A, Addante F, Franceschi M et al. A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure. Circ Heart Fail 2010; 3: Pilotto A, Sancarlo D, Franceschi M et al. A multidimensional approach to the geriatric patient with chronic kidney disease. J Nephrol 2010; 23: S5-10. Pilotto A, Rengo F, Marchionni N, Sancarlo D, Fontana A, Panza F, Ferrucci L on behalf of the FIRI-SIGG Study group. Comparing the prognostic accuracy for all-cause mortality of the Frailty Instruments: a multicentre 1-year follow-up in hospitalized older patients. PLosOne 2012; 7(1): e29090 (1-9). Pilotto A, Panza F, Ferrucci L. A Multidimensional Prognostic Index in Common Conditions Leading to Death in Older Patients. Arch Intern Med 2012; 172 (7): Pilotto A, Gallina P, Fontana A, et al. Development and validation of a multidimensional prognostic index for mortality based on a standardized Multidimensional Assessment Schedule (MPI-SVaMA) in community-dwelling older subjects. J Am Med Dir Assoc 2013;14: Pilotto A, Sancarlo D, Polidori MC on behalf of the MPI_ AGE Investigators. The MPI_AGE European Project: Using Multidimensional Prognostic Indices (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons. Background, aim and design. Eur Geriatr Med 2015;6: Pilotto A, Panza F, Copetti M, et al. on behalf of the MPI_AGE Project Investigators. Statin treatment and mortality in community-dwelling frail older patients with diabetes mellitus: a retrospective observational study. PLoS One 2015;10:e Pilotto A, Arboretti GR, Panza F et al. on behalf of the MPI_AGE Investigators. Role of anti-dementia drugs and multidimensional impairment on mortality rates in frail multimorbid older patients with dementia: results from the European MPI_AGE project. 11th Congress of the EUGMS (European Union Geriatric Medicine Society), Oslo, Norway, September Eur Geriatr Med 2015; 6(S1): S20. Pilotto A, Sancarlo D, Rengo F, et al. on behalf of the FIRI SIGG Study Group. The Multidimensional Prognostic Index predicts in-hospital length of stay in older patients: a multicenter prospective study. Age Ageing 2016;45: Pilotto A, Gallina P, Copetti M et al. on behalf of the Multidimensional Prognostic Index_Age Project Investigators. Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study. J Am Geriatr Soc 2016 Jul;64(7): Pilotto A, Gallina P, Panza F, et al. on behalf of the Multidimensional Prognostic Index_Age Project Investigators. Relation of statin use and mortality in community-dwelling frail older patients with coronary artery disease Am J Cardiol Dec;118(11): Pilotto A, Cella A, Pilotto A et al. Three decades of Comprehensive Geriatric Assessment: evidence coming from different healthcare settings and specifric clinical conditions. J Am Med Dir Assoc. 2017; 18(2):192.e1-192.e11. Sancarlo D, D Onofrio G, Franceschi M et al. Validation of a modified Multidimensional Prognotic Index (m-mpi) including the Mini Nutritional Assessment Short-form (MNA-SF) for the prediction of one-year mortality in hospitalized elderly patients. J Nutr Health Aging 2011; 15: Sancarlo D, Pilotto A, Panza F et al. A Multidimensional Prognostic Index (MPI) based on a Comprehensive Geriatric Assessment predicts short- and long-term all-cause mortality in hospitalized older patients with Transient Ischemic Attach. J Neurol 2012; 259: Siontis GC, Tzoulaki I, Ioannidis JP. Predicting death: an empirical evaluation of predictive tools for mortality. Arch Intern Med 2011; 171: Sultana J, Basile G, Trifirò G. Measuring frailty in population-based healthcare databases: multi-dimensional prognostic indices for the improvement of geriatric care. Geriatric Care 2016; 2: Sultana J, Fontana A, Giorgianni F, et al. Multidimensional frailty indicators in a nationwide GP database predict mortality in the elderly: MPI_AGE results. 11th Congress of the EUGMS (European Union Geriatric Medicine Society), Oslo, Norway, September Eur Geriatr Med 2015;6(S1):S23. Volpato S, Bazzano S, Fontana A, Ferrucci L, Pilotto A on behalf of the MPI-TriVeneto Study Group. Multidimensional Prognostic Index predicts mortality and length of stay during hospitalization in the older patients: a multicenter prospective study. J Gerontol A Biol Sci Med Sci 2015; 70 (3): Volpato S, Daragjati J, Simonato M, et al. Change in the multidimensional prognostic index score during hospitalization in older patients. Rejuvenation Res 2016;19: Warnier RMJ, Van Rossum E, Van Velthuijsen E, et al. Validity, reliability and feasibility of tools to identify frail older patients in inpatient hospital care: a systematic review. J Nutr Health Aging 2016;20:218-3 Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older adults: a systematic review. JAMA 2012; 307:
8 LEAD PARTNER AULSS 6 Euganea Padova Via E. degli Scrovegni, Padova Italy Website: geriatria.osa@aulss6.veneto.it COMMUNICATION LEADER EUGMS - European Geriatric Medicine Society Secretariat Vienna - Laudongasse, 21/ Vienna Austria secretariat@eugms.org PROJECT LEADER Dr. Alberto Pilotto - E.O. Galliera Hospital Mura delle Cappuccine, Genova Italy alberto.pilotto@galliera.it WEB & MEDIA
FINAL REPORT DECISION MAKERS BACKGROUND INFORMATION AND RECOMMENDATIONS
Using Multidimensional Prognostic Indices to improve cost-effectiveness of interventions in multimorbid, frail older persons FINAL REPORT DECISION MAKERS BACKGROUND INFORMATION AND RECOMMENDATIONS INTRODUCTION
More informationTable Of Content. Outputs... 7
Table Of Content Using Multidimensional Prognostic Indices(MPI)to improve costeffectiveness of interventions in multimorbid frail older persons.... 2 Summary... 3 Coordinator, Leader contact and partners...
More informationWork Package 4 Analysis on the use of predictive rules in clinical decision making in community - dwelling older people.
Work Package 4 Analysis on the use of predictive rules in clinical decision making in community - dwelling older people. Deliverable n. 7 Analysis report on the use of predictive rules in clinical decision
More informationGeriatric screening tools in older patients with cancer
Geriatric screening tools in older patients with cancer Pr. Elena Paillaud Henri Mondor hospital, Créteil, France University Paris-Est Créteil CONFLICT OF INTEREST DISCLOSURE I have the following potential
More informationTable Of Content. Appropriate care paths for frail elderly patients: a comprehensive model... 2 Summary... 3 Work Package... 7
Table Of Content Appropriate care paths for frail elderly patients: a comprehensive model... 2 Summary... 3 Work Package... 7 Coordination of the project... 7 Dissemination of the project... 7 Evaluation
More informationWork package 5 Using MPI to improve cost effectiveness of drug treatmens in the olders with multimorbidity and polipharmacy
Work package 5 Using MPI to improve cost effectiveness of drug treatmens in the olders with multimorbidity and polipharmacy Deliverable n. 8 Report on the use of CGA based MPI in improving cost effectiveness
More informationAssessing older patients with hematological malignancies
Assessing older patients with hematological malignancies Alfonso J. Cruz Jentoft Servicio de Geriatría Hospital Universitario Ramón y Cajal Madrid, Spain Is old = frail? 45 days old 2,000 years old 4,600
More informationTHE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures
THE CVD CHALLENGE IN NORTHERN IRELAND Together we can save lives and reduce NHS pressures The challenge of CVD continues today. Around 225,000 people in Northern Ireland live with the burden of cardiovascular
More informationComparing the Prognostic Accuracy for All-Cause Mortality of Frailty Instruments: A Multicentre 1-Year Follow-Up in Hospitalized Older Patients
Comparing the Prognostic Accuracy for All-Cause Mortality of Frailty Instruments: A Multicentre 1-Year Follow-Up in Hospitalized Older Patients Alberto Pilotto 1,2 *, Franco Rengo 3,4, Niccolò Marchionni
More informationEIP AHA Valencia 2016 Towards an Active and Healthy Ageing. Emilia-Romagna Region - Reference Site EIP-AHA
EIP AHA Valencia 2016 Towards an Active and Healthy Ageing Emilia-Romagna Region - Reference Site EIP-AHA A Regional Model to Predict Identify and Manage Multimorbidity and Frailty Mirca Barbolini Valencia
More informationTable Of Content. A European Network of Centres of Reference for Dysmorphology... 2 Summary... 3 Coordinator, Leader contact and partners...
Table Of Content A European Network of Centres of Reference for Dysmorphology... 2 Summary... 3 Coordinator, Leader contact and partners... 4 The Children's Memorial Health Institute IPCZD... 4 Katholieke
More informationWork package 6, task 2: Review existing care (pathway) approaches for multi-morbidity patients
Work package 6, task 2: Review existing care (pathway) approaches for multi-morbidity patients Mieke Rijken Petra Hopman Janneke Noordman Franςois Schellevis Two activities:.. provide an overview of integrated
More informationAll about interrai. Len Gray Coordinator, interrai Network of Excellence in Acute Care April
All about interrai Len Gray Coordinator, interrai Network of Excellence in Acute Care April 2014 The interrai research collaborative Australia Belgium Canada Chile China Czech Republic Denmark Estonia
More informationEIP-AHA A3 Action Group F2F Meeting SUNFRAIL Preliminary Results
EIP-AHA A3 Action Group F2F Meeting SUNFRAIL Preliminary Results University of Valencia Emilia-Romagna Region Mirca Barbolini Marcello Maggio & SUNFRAIL TEAM Valencia, 29 th. June 2017 SUNFRAIL Project
More informationEuropean Collaboration on Dementia. Luxembourg, 13 December 2006
European Collaboration on Dementia Luxembourg, 13 December 2006 2005 Call for projects Special attention has also to be given to information and definition of indicators on neurodegenerative, neurodevelopment,
More informationThe Geriatrician in the Trauma Service. Trauma Quality Improvement Program (TQIP) Annual Scientific Meeting and Training 2013
The Geriatrician in the Trauma Service Trauma Quality Improvement Program (TQIP) Annual Scientific Meeting and Training 2013 Challenges of the Geriatric Trauma Patient Challenges of the Geriatric Patient
More informationNon-commercial use only
Italian Journal of Medicine 2015; volume 9:120-124 Complexity of patients with chronic obstructive pulmonary disease hospitalized in internal medicine: a survey by FADOI Carlo Nozzoli, 1 Luigi Anastasio,
More informationESPEN Congress Leipzig Prognostic impact of body composition
ESPEN Congress Leipzig 2013 Prognostic impact of body composition Malnutrition and body composition changes in neurodegenerative diseases: as bad as in chronic diseases? E. Cereda (IT) Malnutrition and
More informationQ1 In which country and city is your centre based?
Q1 In which country and city is your centre based? Answered: 41 Skipped: 0 # Date 1 Poland, Warsaw 7/2/2017 11:55 PM 2 Poland, Polanica Zdrój 7/2/2017 10:08 PM 3 Poland 6/30/2017 11:34 PM 4 italy 6/30/2017
More informationComprehensive Assessment of the Frail Older Patient
Comprehensive Assessment of the Frail Older Patient Executive Summary Comprehensive geriatric assessment (CGA) is a multidimensional and usually interdisciplinary diagnostic process designed to determine
More informationTable Of Content. Outputs... 9
Table Of Content A european pilot network of reference centres in refractory epilepsy and epilepsy surgery... 2 Summary... 3 Coordinator, Leader contact and partners... 6 UNIVERSITAIR MEDISCH CENTRUM UTRECHT...
More informationProject Meeting Prague
Project Meeting Prague IO1 Assessment 9.11.217 CHRISTINA PADBERG ON BEHALF OF FRANKFURT UAS Current Status Assessment matrix was fully evaluated Experts have been interviewed, Interviews were fully evaluated
More informationEND OF LIFE CARE FOR THE FRAIL ELDERLY
Intensive Care Unit END OF LIFE CARE FOR THE FRAIL ELDERLY Ken Hillman Interface of Palliative Care and ICU/Critical Care. Palliative Care South Australia. 19 March 2018. Adelaide. THE CHALLENGE Increasing
More informationi-abc - Inhaled antibiotics in bronchiectasis and cystic fibrosis
PROYECTOS EUROPEOS EN LOS QUE PARTICIPA EL IRYCIS Innovative Medicines Initative i-abc - Inhaled antibiotics in bronchiectasis and cystic fibrosis http://www.imi.europa.eu/content/iabc Start Date: 01/08/2015
More informationThe COLLaboration on AGEing (COLLAGE)
The COLLaboration on AGEing (COLLAGE) Professor D. William Molloy University College Cork, Ireland. The Lessons from Europe Seminar 23-09-15 Overview Exemplars within COLLAGE: 1. What is COLLAGE? 2. The
More informationEarly release, published at on June 8, Subject to revision.
CMAJ Early release, published at www.cmaj.ca on June 8, 215. Subject to revision. Research External validation of the Hospital-patient One-year Mortality Risk (HOMR) model for predicting death within 1
More informationNutrition to prevent and treat sarcopenia in older people
1 Nutrition to prevent and treat sarcopenia in older people Alfonso J. Cruz-Jentoft Hospital Universitario Ramón y Cajal Madrid, Spain Roma, 17 dicembre 2014 + The objective of Gerontology is not to increase
More informationThe health economic landscape of cancer in Europe
1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor
More informationSubmission on the Draft National Clinical Practice Guidelines for Dementia in Australia
Submission on the Draft National Clinical Practice Guidelines for Dementia in Australia 4 June 2015 details Name of organisation Royal Australian College of General Practitioners () Postal Address Legal
More informationAcute care for older people with frailty
Acute care for older people with frailty Professor Simon Conroy Clinical lead, Acute Frailty Network, England Geriatrician, University Hospitals of Leicester Worldview that will colour this talk Demography
More informationAldo P. Maggioni, Kees Van Gool, Nelly Biondi, Renato Urso, Niek Klazinga, Roberto Ferrari, Nikolaos Maniadakis and Luigi Tavazzi.
Appropriateness of prescriptions of recommended treatments in OECD health systems: findings based on the Long-Term Registry of the ESC on Heart Failure Aldo P. Maggioni, Kees Van Gool, Nelly Biondi, Renato
More informationStudy period Total sample size (% women) 899 (37.7%) Warfarin Aspirin
Table S2 Sex- specific differences in oral anticoagulant prescription for stroke prevention in AF Total sample size (% women) Anticoagulant(s) studied Gage (2000) 1 Missouri, USA Discharged during 597
More informationA Global perspective on Heart Failure: What needs to change? Martin R Cowie London, United Kingdom
A Global perspective on Heart Failure: What needs to change? Martin R Cowie London, United Kingdom Global perspective on heart failure: what needs to change? Martin R Cowie Professor of Cardiology National
More informationPolymedication in nursing home. Graziano Onder Centro Medicina dell Invecchiamento Università Cattolica del Sacro Cuore Rome - Italy
Polymedication in nursing home Graziano Onder Centro Medicina dell Invecchiamento Università Cattolica del Sacro Cuore Rome - Italy Services and Health for Elderly in Long TERm care (SHELTER) 4156 residents
More informationA PATIENT S GUIDE TO THE LEFT ATRIAL APPENDAGE CLOSURE. Reducing the risk of stroke in atrial fibrillation
A PATIENT S GUIDE TO THE LEFT ATRIAL APPENDAGE CLOSURE Reducing the risk of stroke in atrial fibrillation TABLE OF CONTENTS IMPORTANT Please Note: Information provided by Boston Scientific Corporation
More informationCurrent dietary habits in Europe far from plant based eating
Current dietary habits in Europe far from plant based eating Stefaan De Henauw Ghent University Department of Public Health Stefaan.dehenauw@ugent.be The menu What is plant based diet? Nutrition transition
More informationSUNFRAIL. limits and potential of the Public Health Programme SUCCESS STORIES OF THE HEALTH PROGRAMME. Emilia-Romagna Region Mirca Barbolini & Team
limits and potential of the Public Health Programme SUCCESS STORIES OF THE HEALTH PROGRAMME SUNFRAIL Emilia-Romagna Region Mirca Barbolini & Team at the European Parliament, Brussels, 22 nd November 2017
More informationGSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationSupporting carers through the web: the road towards a new European web platform
Supporting carers through the web: the road towards a new European web platform Areti Efthymiou Eurocarers On behalf of the research team composed by: G. Lamura, F. Barbabella, C. Lancioni, R. Papa, A.
More informationSecondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION
Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION Dr Kornelia Kotseva National Heart & Lung Insitute Imperial College London, UK on behalf of all investigators participating
More informationAged Care and Health Services Research. A/Prof Kwang Lim Sep 2016
Aged Care and Health Services Research A/Prof Kwang Lim Sep 2016 Accumulating evidence 20% of health care interventions is based on hard evidence. Feasibility of doing randomised controlled trials on all
More informationAndrea Ungar, MD, PhD, FESC
TRATTAMENTO ENDOVASCOLARE DELLE VALVULOPATIE: NON SOLO LA TAVI Andrea Ungar, MD, PhD, FESC Dept. of Geriatrics and Intensive Care University of Florence, Italy EUGMS Special Interest Group on Valvular
More informationthe high CVD risk smoker
Smoking Cessation: population and patients A comprehensive approach to the smoker the high CVD risk smoker Catriona Jennings Cardiovascular Specialist Research Nurse Imperial College London European Society
More informationPress Release. Page 1 of 5
Press Release Daiichi Sankyo Initiates ENVISAGE-TAVI AF Study Investigating Once-Daily Lixiana (edoxaban) in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Implantation ENVISAGE-TAVI
More informationOn behalf of E-PILEPSY consortium Philippe Ryvlin (Lyon, France)
A European pilot network of reference centres in refractory epilepsy and epilepsy surgery On behalf of E-PILEPSY consortium Philippe Ryvlin (Lyon, France) Brussels, Written Declaration on Epilepsy! 6.000.000
More informationCOUNTRY REPORT OF VIET NAM AT THE 12 TH ASEAN & JAPAN HIGH LEVEL OFFICIALS MEETING ON CARING SOCIETIES
COUNTRY REPORT OF VIET NAM AT THE 12 TH ASEAN & JAPAN HIGH LEVEL OFFICIALS MEETING ON CARING SOCIETIES 21-23 OCTOBER 2014 I. AGEING POPULATION IN VIETNAM 1. Vietnam is one of 10 countries with the world
More information*GERIATRIC FELLOWSHIP COMPETENCY CHECKLIST EDUCATIONAL GOALS:
*GERIATRIC FELLOWSHIP COMPETENCY CHECKLIST EDUCATIONAL GOALS: The goal of geriatric fellowship training is to prepare fellows for competency in the following core areas: Check and record date completed
More informationMeasles and rubella monitoring January 2015
Measles and rubella monitoring January 215 Reporting on January December 214 surveillance data and epidemic intelligence data to the end of January 215 Main developments Measles During the 12-month period
More informationFUNDACIÓN INVESTIGACIÓN BIOMÉDICA HOSPITAL UNIVERSITARIO GETAFE. Dr. Marta Checa Prof. Rodríguez Mañas MD, PhD Geriatrician H. U.
FUNDACIÓN INVESTIGACIÓN BIOMÉDICA HOSPITAL UNIVERSITARIO GETAFE Dr. Marta Checa Prof. Rodríguez Mañas MD, PhD Geriatrician H. U. Getafe (Madrid) Our research projects as Coordinator A comprehensive validation
More informationProspective Evaluation of the Eyeball Test for Assessing Frailty in Elderly Patients with Valvular Heart Disease
Prospective Evaluation of the Eyeball Test for Assessing Frailty in Elderly Patients with Valvular Heart Disease Background Frailty is a common occurrence in elderly patients Approximately half of the
More informationHyperlipidemia in an Otherwise Healthy 80 Year-Old Patient. Theodore D Fraker, Jr, MD Professor of Medicine
Hyperlipidemia in an Otherwise Healthy Theodore D Fraker, Jr, MD Professor of Medicine Orlando, Florida October 7-9, 2011 80-Year-Old Patient Primary Prevention Issues in the Elderly: Coronary artery disease
More informationTAVI SURVEY. Performed by the ESC Council for Cardiology Practice
TAVI SURVEY Performed by the ESC Council for Cardiology Practice BACKGROUND To evaluate the knowledge and the behaviour of a large community of cardiologists working in different settings, both in hospital
More informationChairs: John Lainchbury & Andrew Aitken. Elderly/Frailty
Frailty Elderly/Frailty Ralph Stewart Chairs: John Lainchbury & Andrew Aitken Elderly/Frailty Ralph Stewart Green Lane Cardiovascular Service and Cardiovascular Research Unit Auckland City Hospital 1 What
More informationGERIATRIC TEACHING AND TRAINING IN EUROPE: Where are we? (part I)
GERIATRIC TEACHING AND TRAINING IN EUROPE: Where are we? (part I) Pr. Olivier Beauchet, MD, PhD Department of Neuroscience Geriatrics Division and Memory Clinic Angers University Hospital and School of
More informationFRAGILITÀ, DISABILITÀ E MALATTIE NELLO STUDIO PRO.V.A. Enzo Manzato (Padova)
FRAGILITÀ, DISABILITÀ E MALATTIE NELLO STUDIO PRO.V.A. Enzo Manzato (Padova) J Am Geriatr Soc 50, 1535, 2002 J Am Geriatr Soc 50, 1535, 2002 Odds Ratios for Activity of Daily Living Disability According
More informationFor the SURTAVI Investigators
Neurological complications after transcatheter aortic valve implantation with a self-expanding bioprosthesis or surgical aortic valve replacement in patients at intermediate-risk for surgery A. Pieter
More informationSUNFRAIL PROJECT Understanding and Caring for Frailty and Multimorbidity. Speaker/Conference/Date
SUNFRAIL PROJECT Understanding and Caring for Frailty and Multimorbidity Speaker/Conference/Date ACKNOWLEDGEMENT This presentation is part of SUNFRAIL (project 664291), which has received funding from
More informationPalliative Care in a Dementia Unit: The Presbyterian Support Southland experience. Carla Arkless NP
Palliative Care in a Dementia Unit: The Presbyterian Support Southland experience Carla Arkless NP Overview What the literature is saying Palliative Care challenges Our experiences Case example What is
More informationPrimary and secondary prevention of sudden cardiac death in emerging economies
Primary and secondary prevention of sudden cardiac death in emerging economies Béla Merkely MD, PhD, DSc, FESC Heart Center Semmelweis University Budapest Common risk factors for sudden cardiac death Increasing
More informationTAVR in patients with. End-Stage CKD or in Renal Replacement Therapy:
TAVR in patients with End-Stage CKD or in Renal Replacement Therapy: Special Considerations and Prevention of early Valve Failure Antonios Chalapas, MD, PhD, FESC THV & Hygeia Hospital Heart Team Athens,
More informationThe Community Assessment of Risk and Treatment Strategies (CARTS) Project. Professor D. William Molloy COLLAGE University College Cork, Ireland.
The Community Assessment of Risk and Treatment Strategies (CARTS) Project Professor D. William Molloy COLLAGE University College Cork, Ireland. Centre for Gerontology and Rehabilitation A time of limited
More informationThe Role of TAVI in high-risk and normal-risk Patients
The Role of TAVI in high-risk and normal-risk Patients Joachim Schofer Hamburg University Cardiovascular Center and Department for percutaneous treatment of structural heart disease Albertinen Heart Center
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #326 (NQF 1525): Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY
More informationThe Impact of TAVI Nurse Coordinator on patient management of Transcatheter Aortic Valve Implantation (TAVI) program in QEH
HA Convention 18-19 May 2015 The Impact of TAVI Nurse Coordinator on patient management of Transcatheter Aortic Valve Implantation (TAVI) program in QEH Division of Cardiology Department of Medicine Queen
More information2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process
Quality ID #326 (NQF 1525): Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Management of Chronic
More informationJoint Programming in Neurodegenerative Disease Research (JPND)
Joint Programming in Neurodegenerative Disease Research (JPND) Building Alliances and Collaborations Prof. Philippe Amouyel, MD, PhD JPND Chair France Disclosure CEO of Fondation Plan Alzheimer Conference
More informationWorkshop 2 Active & Healthy Ageing: Pain management for an improved quality of life
Workshop 2 Active & Healthy Ageing: Pain management for an improved quality of life Per Kjaersgaard-Andersen, MD, Ass proff Secretary General EFORT European Federation of National Associations of Orthopaedics
More informationVision for quality: A framework for action - technical document
3. Frailty Vision for quality: A framework for action - technical document Contents 1.0 Introduction 1 2.0 The current situation in Warwickshire North 2 3.0 The case for change 4 4.0 Views and opinions
More informationUrban Health Centres Europe (UHCE) Integrated social and health care to promote quality of life and independent living
E-mail: info@uhce.eu Website: http://uhce.eu/ Hein Raat, Carmen Franse, Elena Curtopassi Urban Health Centres Europe (UHCE) Integrated social and health care to promote quality of life and independent
More informationRheumatoid Arthritis Disease Burden and Access to Treatment
Berlin, April 2012 Rheumatoid Arthritis Disease Burden and Access to Treatment Gisela Kobelt, PhD Visiting Professor, Lund University (Sweden) President, European Health Economics (France) Disclaimers
More informationAssessment report. for
Assessment report for FABRAZYME agalsidase beta Assessment report on the shortage of Fabrazyme Overview of Shortage Period: Spontaneous Reports from June 2009 through 15 September and Registry Data from
More informationInspection/examination of the ureter & biopsy : procedure-specific information
PATIENT INFORMATION Inspection/examination of the ureter & biopsy : procedure-specific information What is the evidence base for this information? This leaflet includes advice from consensus panels, the
More informationManagement of the Frail Older Patients: What Are the Outcomes
Management of the Frail Older Patients: What Are the Outcomes Professor Edwina Brown Imperial College Renal and Transplant Centre Hammersmith Hospital, London Increasing prevalence of old old on RRT RRT
More informationINTERDEM MEMBERS BRIEF CURRICULUM VITAE
INTERDEM MEMBERS BRIEF CURRICULUM VITAE NAME: Marieke Perry TITLE: TITLE: MD, PhD PROFESSIONAL GROUPING: PROFESSIONAL GROUPING: General Practitioner WORK ADDRESS: WORK ADDRESS: 925 Geriatric Medicine TEL:
More information30-day Outcomes of The CENTERA Trial a New Self-Expanding Transcatheter Heart Valve. Didier Tchétché, MD On Behalf of the CENTERA Investigators
30-day Outcomes of The CENTERA Trial a New Self-Expanding Transcatheter Heart Valve Didier Tchétché, MD On Behalf of the CENTERA Investigators Speaker's name: Didier Tchétché, MD I have the following potential
More informationTop Papers in Critical Care Janna Landsperger, ACNP-BC
Top Papers in Critical Care 2014 Janna Landsperger, ACNP-BC Objectives Review journal articles regarding delivery of critical care published over the past twelve months Provide evidence in support of current
More informationSUPPLEMENTARY INFORMATION
Table S1 Sex- specific differences in rate- control and rhythm- control strategies in observational studies Study region Study period Total sample size Sex- specific results Ozcan (2001) 1 Mayo Clinic,
More informationImproving Healthcare Utilization in Injured Older Adults
Improving Healthcare Utilization in Injured Older Adults G ERIATRIC T R A U MA I N I T I AT I V E S AT S TA N F O R D H E A LT H C A R E J U LY 12, 2018 Objectives Background on Geriatric Trauma Population
More informationTable Of Content. The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...
Table Of Content The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Institut Pasteur... 6 Health Division... 6 Nphs Communicable Disease Surveillance
More informationAntithrombotic. DAPT or OAC?
Antithrombotic treatment after TAVI: DAPT or OAC? Striking the right balance. Pascal Vranckx MD, PhD. Hartcentrum Hasselt, Belgium. Disclosure of Interest Pascal Vranckx has the following potential conflicts
More informationNICE Indicator Programme. Consultation on proposed amendments to current QOF indicators
NICE Indicator Programme Consultation on proposed amendments to current QOF s Consultation dates: 18 July to 1 August 2018 This document outlines proposed amendments to a small number of QOF s in the diabetes
More information1-YEAR OUTCOMES FROM JOHN WEBB, MD
1-YEAR OUTCOMES FROM JOHN WEBB, MD ON BEHALF OF THE SAPIEN 3 INVESTIGATORS UNIVERSITY OF BRITISH COLUMBIA VANCOUVER, CANADA Potential conflicts of interest Speaker's name: John Webb I have the following
More informationSaudi Arabia February Pr Michel KOMAJDA. Université Pierre et Marie Curie Hospital Pitié Salpétrière
Prevention of Cardiovascular events with Ivabradine: The SHIFT Study Saudi Arabia February 2011 Pr Michel KOMAJDA Université Pierre et Marie Curie Hospital Pitié Salpétrière Paris FRANCE Declaration Of
More informationAlzheimer Europe. European Collaboration on Dementia
Alzheimer Europe European Collaboration on Dementia Members Care Manual Audience: Informal caregivers Analysis of existing information and data Tips for carers Available on AE website and in DE, FR, IT,
More informationSummary of Research and Writing Activities In Cardiovascular Disease
Summary of Research and Writing Activities In Cardiovascular Disease Carole Alison Chrvala, PhD 919.545.2149 (Work) 919.951.5230 (Mobile) cchrvala@centurylink.net www.healthmattersmedwriting.com 1 Manuscripts
More informationMulticentre clinical study evaluating a novel resheatable self-expanding transcatheter aortic valve system
Multicentre clinical study evaluating a novel resheatable self-expanding transcatheter aortic valve system Preliminary Results: Acute and 1-year Outcomes Ganesh Manoharan, MBBCh, MD, FRCP Consultant Cardiologist
More informationASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS
ASPIRIN MISUSE AT HOME ACCORDING TO START AND STOPP IN FRAIL OLDER PERSONS O. Dalleur 1,4, B. Boland 2,3, A. Spinewine 4-5 1 Pharmacy and 2 Geriatric Medicine, St-Luc university Hospital, 3 Institute of
More informationIntegrating Geriatrics into Oncology Care
Integrating Geriatrics into Oncology Care William Dale, MD, PhD Chief, Geriatrics & Palliative Medicine Director, Specialized Oncology Care & Research in the Elderly (SOCARE) Clinic University of Chicago
More informationMolecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
SURVEILLANCE REPORT Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA March 2017 Summary This report describes the geographical and temporal distribution of multidrug-resistant
More informationIntegrating Medical and Social Support for Elderly System & Technology Enabled Service Innovations. Dr Christina MAW Hospital Authority, Hong Kong
Integrating Medical and Social Support for Elderly System & Technology Enabled Service Innovations Dr Christina MAW Hospital Authority, Hong Kong Hospital Authority (HA) of Hong Kong A statutory body responsible
More informationStrokes After TAVR Reasons for Declining Frequency
Strokes After TAVR Reasons for Declining Frequency Samir Kapadia, MD Professor of Medicine Director, Cardiac Catheterization Laboratory Cleveland Clinic Disclosure NONE Second Generation Valves Newer
More informationPalliative Care in Aged Residential Care: How does it effect staff?
Palliative Care in Aged Residential Care: How does it effect staff? Dr Michal Boyd, RN, NP, ND, FCNA (NZ), FAANP Sr. Lecturer and Gerontology Nurse Practitioner University of Auckland School of Nursing
More informationTable Of Content. European Collaboration on Dementia... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...
Table Of Content European Collaboration on Dementia... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Associacao Portuguesa de Familiares e Amigos de Doentes de Alzheimer... 5 Universiteit
More informationMonthly measles and rubella monitoring report
SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data
More informationPre- Cardiac intervention. Dr. Victor Sim 26 th Sept 2014
Pre- Cardiac intervention Frailty assessment Dr. Victor Sim 26 th Sept 2014 Defining frailty Lacks consensus (Rockwood CMAJ 2005;173(5):489-95 Introduction) Some consider symptoms, signs, diseases and
More informationReal-World Insights from GARFIELD-AF Registry Presented at ESC Congress 2017
Real-World Insights from GARFIELD-AF Registry Presented at ESC Congress 2017 One of the aims of GARFIELD-AF is to assist physicians in their understanding of the risk of stroke in patients with atrial
More informationNICE guideline Published: 21 September 2016 nice.org.uk/guidance/ng56
Multimorbidity: clinical assessment and management NICE guideline Published: 21 September 2016 nice.org.uk/guidance/ng56 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationCHRODIS Kick-off. Communication and Dissemination. Cristina Chiotan / Anna Gallinat Public Health Coordinator / Communications Assistant
CHRODIS Kick-off Communication and Dissemination Cristina Chiotan / Anna Gallinat Public Health Coordinator / Communications Assistant EuroHealthNet The European Partnership for improving health, equity
More informationTranscatheter Aortic Valve Replacement with a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients:
Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 1-Year Results from the SURTAVI Clinical Trial Nicolas M. Van
More informationAN INNOVATIVE APPROCH TOWARDS IDENTIFICAION OF NOVEL THERAPEUTIC DRUG TARGETS TO IMPROVE THE MANAGEMENT OF HEART FAILURE
AN INNOVATIVE APPROCH TOWARDS IDENTIFICAION OF NOVEL THERAPEUTIC DRUG TARGETS TO IMPROVE THE MANAGEMENT OF HEART FAILURE Cardiology, New solutions for drug development, Cutting-edge technologies, Multi-disciplinary
More information